Project Grant R44GM145102

Award Date 3/17/22
Completion Date 7/31/25
Dollars Obligated $1.8M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Peoria, IL 61606, USA
Similar Awards
This $575,000 project grant awarded by the National Science Foundation's (NSF) Division of Chemistry (CFDA 47.049 - Mathematical and Physical Sciences) will support a research effort led by Professor George O'Doherty at Northeastern University to develop novel synthetic methods for the asymmetric synthesis of oligosaccharide structures. The project aims to enable the efficient, de novo construction of both natural and unnatural oligosaccharide motifs, which have important applications in biology...
This $290,986 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) aims to synthesize a comprehensive library of 38 structurally defined sulfated O-GalNAc glycans. The Sulfated Modular Synthesis/Enzymatic Assembly (SMSEA) approach will be used to create this glycan library, which will serve as an invaluable toolkit for functional glycomics research to advance the understanding of the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) award provides $274,727 to Weka Biosciences LLC, a woman-owned small business, to develop a novel microbial process for creating a synthetic sugar polymer for use in chiral chromatography. The goal is to produce a more reliable and efficient polymer material to enhance the precision of drug manufacturing and contribute to safer, more effective medications. The 12-month project will focus on...
This $561,306 Project Grant, awarded by the USDA National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (CFDA 10.310), will support research conducted by Utah State University to evaluate the physical properties and potential applications of rare sugars, such as D-psicose, D-tagatose, and isomaltulose, in confectionery products. The key objectives of the 4-year project are to: (1) assess the physical characteristics of these rare sugars, (2) quantify...
This Project Grant award from the National Institutes of Health's National Human Genome Research Institute provided $768,678 to Molecular Assemblies, Inc. to develop a fully enzymatic oligonucleotide synthesis cycle using engineered template-independent polymerases and a novel phosphate dNTP blocking group. The award supports the goals of the Human Genome Research program (CFDA 93.172) to accelerate genome research and its application to human health. Specifically, the awardee will engineer...
This Project Grant award of $408,007 from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop a technology called "glycosequencing" that uses next-generation sequencing (NGS) to sequence and quantify glycan structures. The project will first identify an optimal set of lectins, biochemically characterize them, and prepare lectin barcoding for NGS. It will also build a training dataset using recombinant proteins produced in glycoengineered Chinese...
The National Institutes of Health National Institute of General Medical Sciences awarded a $903,000 Project Grant to The University of Toledo to develop new glycosylation methods for microbial glycan synthesis under the Biomedical Research and Research Training program (CFDA 93.859). Over a three-year period from September 2022 to August 2025, the University will create two new catalytic glycosylation methodologies - a cationic gold(I)-catalyzed glycosylation using glycosyl...
Exopolymer, Inc. received a $648,366 Small Business Innovation Research (SBIR) Project Grant from the Department of Agriculture's National Institute of Food and Agriculture to develop new fermentation-derived biopolymer ingredients. Under this two-year award running from September 2021 to August 2023, Exopolymer will finalize the commercial development of one or more biopolymer products that outperform hyaluronic acid in moisture binding and skin penetration performance. Work will include...
This Project Grant award from the National Science Foundation (NSF) under the Biological Sciences program (CFDA 47.074) provides $369,297 to San Francisco State University (SFSU) to develop a synthetic transhydrogenation module to enhance the production of valuable chemicals using engineered organisms. The key objectives are to: Elucidate the structural mechanisms underlying the autoregulation of the GltAB-GudB enzyme complex in Bacillus subtilis, which regulates glutamate metabolism and impacts...
This $300,000 Project Grant awarded by the USDA's Agriculture and Food Research Initiative (CFDA 10.310) aims to demonstrate the feasibility of producing chirally pure (R)-3-hydroxybutyrate (R-3HB) from plant waste materials, such as wood and crop leftovers, by modifying Clostridium pathways. The research will create and test two different R-3HB production pathways in Clostridium, then combine and further optimize the approaches to boost R-3HB yields in the bacterium. If successful, this work...

PRODUCTION OF NATURAL DEOXYSUGARS FOR USE IN CHEMICAL SYNTHESIS OF GLYCOSIDES - PROJECT SUMMARY THE GOAL OF THE PROPOSAL PRESENTED HEREIN IS TO PRODUCE NATURALLY OCCURRING 6-DEOXYSUGARS, INCLUDING DI- AND TRI-DEOXYSUGARS, AMINO SUGARS AND BRANCHED-CHAIN SUGARS. THESE SPECIALIZED HEXOSES ARE FOUND AS IMPORTANT STRUCTURAL COMPONENTS THROUGHOUT PLANT AND MICROBIAL SECONDARY METABOLITES, OFTEN PLAYING A CRUCIAL ROLE IN CONFERRING ACTIVITY IN BIOACTIVE NATURAL PRODUCTS, SUCH AS ANTIBIOTICS AND ANTICANCER THERAPEUTICS. THEY ARE OF INCREASING INTEREST IN GLYCOENGINEERING EFFORTS, WHICH AIM TO ALTER SUGAR SUBSTITUENTS FOUND ON GLYCOSYLATED NATURAL PRODUCTS OR APPEND SUGAR MOIETIES TO NON-GLYCOSYLATED NATURAL PRODUCTS. IN NATURE, 6-DEOXYSUGARS ARE FREQUENTLY BUILT UP AND MODIFIED AS PART OF ACTIVATED DTDP-NUCLEOSIDE SUGARS INSTEAD OF INDEPENDENT MOLECULES. WE PROPOSE TO INVESTIGATE A NOVEL APPROACH TO PRODUCE THESE RARE DEOXYSUGARS USING A PROPRIETARY E. COLI SYSTEM WE FIRST DEVELOPED TO PRODUCE ACTIVATED TDP-DEOXYSUGARS. TO DO THIS, THERE WERE SEVERAL CHALLENGES TO ADDRESS IN THE PHASE I FEASIBILITY STUDY. FIRST, TITERS OF THE TDP- DEOXYSUGARS NEEDED TO BE INCREASED, PREFERENTIALLY ACCUMULATING MORE MATERIAL IN THE GROWTH MEDIUM. SECOND, AN EFFECTIVE WAY TO SEPARATE AND PURIFY THE MOLECULES FROM THE GROWTH MEDIUM NEEDED TO BE DEVELOPED. FINALLY, THE DEOXYSUGARS NEEDED TO BE HYDROLYZED AND ISOLATED. IN PHASE I WE DEMONSTRATED THE FEASIBILITY OF DEOXYSUGAR PRODUCTION USING D-FUCOSE DERIVED FROM DTDP- D-FUCOSE AS A MODEL. THIS WAS ACCOMPLISHED BY 1) INCREASING PRODUCTION OF DTDP-D-FUCOSE BY ENHANCING EXPRESSION AND SOLUBILITY OF FCF1, THE ENZYME USED TO MAKE DTDP-D-FUCOSE FROM TKDG, 2) DETERMINING A MEDIUM CAPABLE OF PRODUCING LARGER QUANTITIES OF DTDP-D-FUCOSE IN THE MEDIUM, 3) DEVELOPING A DTDP-D-FUCOSE PURIFICATION PROTOCOL FROM THE MEDIUM, 4) DEVELOPING A METHOD FOR HYDROLYSIS OF DTDP-D-FUCOSE AND THE SUBSEQUENT PURIFICATION OF D-FUCOSE. IN PHASE II, WE WILL EXPAND THE PROCESS TO MANUFACTURE 18 ADDITIONAL DEOXYSUGARS FROM DTDP- DEOXYSUGARS. FURTHER OPTIMIZATION OF THE DTDP-DEOXYSUGAR PRODUCTION PATHWAYS WILL BE CONDUCTED TO INCREASE THE AMOUNT IN THE MEDIUM TO 0.5-1.0 G/L. THIS WILL ALLOW US TO PRODUCE UP TO A 2.5 G OF EACH DEOXYSUGAR FROM A SINGLE 10 L FERMENTER. IN PHASE III, WE WILL COMMERCIALIZE THE DEOXYSUGARS, INDIVIDUALLY AND AS A KIT, TO RESEARCHERS IN ACADEMIA AND INDUSTRY. THROUGH EXPANDED PRODUCTION, THE WORK DONE IN PHASE II WILL ALSO HELP INCREASE PRODUCTION OF THE DTDP-ACTIVATED DEOXYSUGARS AS IMPORTANT SECONDARY PRODUCTS.

Posted 9/8/23, 12:00 AM